Bullboard - Stock Discussion Forum Applied DNA Sciences Inc APDN

Technology Scientific & Technical Instruments

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Add To Watchlist

NDAQ:APDN - Post Discussion

Applied DNA Sciences Inc > Hayward's Hiding Something

View:

Post by turner20001 on Nov 20, 2023 3:22pm

Hayward's Hiding Something

Here's the rest of the story Hayward is hiding from you. An AI search for companies working on mRNA Therapeutics doesn't even mention Applied DNA Junk Sciences.

Here are some of the major companies involved in mRNA therapeutics:

Leading Companies

Moderna: A pioneer in mRNA technology, Moderna developed the first mRNA vaccine approved for commercial use, Comirnaty, against COVID-19. They have a pipeline of mRNA vaccines and therapeutics for various diseases, including influenza, cytomegalovirus, and cancer.
BioNTech: Partnered with Pfizer to develop the Comirnaty COVID-19 vaccine, BioNTech is also advancing mRNA therapeutics for cancer and infectious diseases. They have collaborations with several pharmaceutical companies and research institutions.
CureVac: A German biotechnology company, CureVac has developed COVID-19 vaccine candidates and is exploring mRNA-based therapies for cancer and other diseases. They have partnerships with GlaxoSmithKline and the Bill & Melinda Gates Foundation.
Arcturus Therapeutics: Focused on developing novel RNA-based therapies, Arcturus has clinical-stage programs for COVID-19, influenza, and cystic fibrosis. They utilize a proprietary LUNAR technology platform for RNA delivery.
Translate Bio: A Massachusetts-based biotech company, Translate Bio specializes in self-amplifying RNA (saRNA) technology. Sanofi acquired Translate Bio in 2021 to expand its mRNA capabilities.